Pokras, Shibani
Pimenta, Jeanne
Merinopoulou, Evie
Lambrelli, Dimitra
Funding for this research was provided by:
GlaxoSmithKline (HO-13-13781)
Article History
Received: 22 September 2017
Accepted: 21 June 2018
First Online: 4 July 2018
Ethics approval and consent to participate
: Utilisation of the SHI sample was approved by the data protection commissioner of the state of Hessen, according to Social Code SGB X ยง 75. For the sample population, the personal data stored by AOK Hessen and KV Hessen were recorded, confidentially pseudonymised, and forwarded to the PMV research group, which conducted the analyses. The members of the Advisory Board Versichertenstichprobe (insurance sample advisory board) were informed about the study; they approved the utilisation of the data, and ruled that that no formal ethics approval was required.
: Not applicable.
: SP and JP are full-time employees of GlaxoSmithKline (GSK) and own stock in GSK. EM and DL are full-time employees of Evidera and served as paid consultants to GSK for conducting this study. The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.